Precision Medicine

In the final installment in this feature series, six health IT leaders discuss where they're investing for the future of genomics and personalized medicine – and forecast the new tools and trends they see on the horizon.

'Our best solutions must be given to everyone,' says Dr. Azizi Seixas, founding director of the medical school's Media and Innovation Lab.

Holmes faced 11 total counts, and the jury found her guilty of four of them. Each carries a maximum sentence of 20 years in prison.

Some of the biggest names in healthcare and technology – athenahealth, Allscripts, Microsoft, Nuance and, of course, Oracle and Cerner – made big news with big-ticket deals this past year.

Dr. Hans Eriksson, chief clinical development officer at HMNC Brain Health, discusses the ways AI-driven precision psychiatry can be leveraged to target the use of medications and improve patient outcomes.

The companies will reportedly focus on exploring real-world evidence and conducting clinical trials through G42 Healthcare’s Contract Research Organisation, IROS.

Deep Dive: Many adults with a mental illness won’t be able to access care, during greater levels of anxiety and depression during COVID-19. Digital tools can help.           

Sirj Goswami, CEO and cofounder of InsightRX, discusses determining proper dosages for individuals.

In the move towards value-based care, digitally maturing healthcare systems can integrate AI to generate high quality data to personalise and integrate care, and even predict and prevent disease. 

Eight C-suite execs offer insights on where they see investments going in the next five years in AI, interoperability, telehealth, cybersecurity, EHRs and emerging technology.